Featured Publications
Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers
Sung ML, Black AC, Blevins D, Henry BF, Cates-Wessel K, Dawes MA, Drexler K, Hagle H, Molfenter T, Levin FR, Becker WC, Edelman EJ. Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers. Journal Of Addiction Medicine 2022, 16: 505-513. PMID: 35020698, PMCID: PMC9271533, DOI: 10.1097/adm.0000000000000948.Peer-Reviewed Original ResearchConceptsVirtual visitsOpioid use disorder careOpioid use disorderAcademic medical centerNational electronic surveyMOUD accessMOUD prescriptionsClinical outcomesBuprenorphine prescribersLongitudinal careMost prescribersMultivariable modelMedical CenterDisorder careUse disordersMOUDPrescribersPatient accessibilityFree-text responsesOverall positive experienceVisitsElectronic surveyCOVID-19COVID-19 pandemicBehavioral healthcareTrauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder
Meshberg-Cohen S, Black AC, DeViva JC, Petrakis IL, Rosen MI. Trauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder. Addictive Behaviors 2018, 89: 29-34. PMID: 30243036, DOI: 10.1016/j.addbeh.2018.09.010.Peer-Reviewed Original ResearchConceptsBuprenorphine maintenanceChart reviewBuprenorphine treatmentTrauma treatmentPTSD diagnosisReference groupRetrospective chart reviewBuprenorphine maintenance treatmentOpioid use disorderFuture clinical trialsLogistic regression analysisEvidence-based psychotherapiesTimes greater oddsTrauma-focused treatmentBuprenorphine retentionOpioid typeOUD treatmentMaintenance treatmentWorse outcomesClinical trialsConsecutive referralsGreater oddsUse disordersComorbid PTSDDisorder rates
2023
Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17
Heimer R, Black A, Lin H, Grau L, Fiellin D, Howell B, Hawk K, D'Onofrio G, Becker W. Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17. Drug And Alcohol Dependence 2023, 254: 111040. PMID: 38043226, PMCID: PMC10872282, DOI: 10.1016/j.drugalcdep.2023.111040.Peer-Reviewed Original ResearchConceptsNon-medication treatmentsRelative riskOpioid overdose deathsIncidence rateMOUD treatmentOverdose deathsOpioid use disorder treatmentResults Incidence ratesRetrospective cohort studyDifferent treatment modalitiesPopulation-level effortsUse disorder treatmentFatal opioid poisoningsCohort studyOpioid poisoningTreatment modalitiesConclusion ExposurePoisoning deathsFatal overdosesTreatment exposureDisorder treatmentDeathTreatmentMethadoneRisk
2022
Self-reported Use of Prescribed Buprenorphine Among US Adults With Nonmedical Use of Prescription Opioids Motivated by Pain
Buonora M, Sung M, Falker C, Black A, Becker W. Self-reported Use of Prescribed Buprenorphine Among US Adults With Nonmedical Use of Prescription Opioids Motivated by Pain. JAMA Network Open 2022, 5: e2241670. PMID: 36367731, PMCID: PMC9652749, DOI: 10.1001/jamanetworkopen.2022.41670.Peer-Reviewed Original Research